Back to dashboard
Medicare AdvantageCoverageMedium impact

Percutaneous Coronary Intervention - Medicare Advantage (Revised)

Humana·Cardiology, Cardiothoracic Surgery, Internal Medicine·Medicare Advantage
Effective date
Not stated
We identified it
Aug 4, 2026
Days to comply

Summary

This is a policy clarification from Humana Medicare Advantage defining percutaneous coronary intervention (PCI) procedures, including coronary angioplasty, stent placement, atherectomy, and intravascular lithotripsy for treating coronary artery narrowing. The policy appears to be informational in nature, establishing coverage parameters for these cardiac interventions rather than announcing a substantive coverage change.

Action Required

Action needed
Billing team should review this policy clarification and cross-reference with existing prior authorization requirements and billing protocols for PCI procedures under Humana Medicare Advantage plans. Verify current system configuration for any of these procedures (angioplasty, stent placement, atherectomy, intravascular lithotripsy) to ensure alignment with this policy definition. No immediate workflow changes are required unless this policy supersedes conflicting guidance previously in use. Document this policy in the team's Medicare Advantage reference materials.